KATHRYN TAYLOR: Open Payments
NPI 1003370701 · WYLIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 80 payments from 18 companies in 2025. Trend: 2023 $1,506 · 2024 $1,228 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $394 |
| GlaxoSmithKline, LLC. | 30 | $354 |
| GENZYME CORPORATION | 12 | $241 |
| Inspire Medical Systems, Inc. | 1 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| HARMONY BIOSCIENCES LLC | 2 | $57 |
| INOGEN, INC. | 3 | $47 |
| Viatris Specialty LLC | 2 | $44 |
| Verona Pharma, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, FASENRA, TRELEGY ELLIPTA, INSPIRE, WAKIX, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
